Healthcare Discovery Alzheimer's blood test image showing p-tau217 biomarkers, finger prick diagnostics, lithium science, and cognitive aging
| | |

Blood Tests Are Rewriting Alzheimer’s Detection: How P-Tau217, Finger Prick Diagnostics, and Lithium Science Are Transforming Cognitive Aging

ByThe Healthcare Discovery Team

A convergence of 2026 studies in Nature Medicine and Nature Aging is transforming Alzheimer’s detection. The p-tau217 blood test clock predicts symptom onset within three to four years, a finger…

GLP-1 drugs cancer risk reduction clinical research ASCO 2026 | Healthcare Discovery
| | |

Liquid Biopsy Is Rewriting Cancer Detection: How a Single Blood Draw May Find Dozens of Cancers Before Symptoms Appear

ByThe Healthcare Discovery Team

A convergence of cfDNA methylation analysis, multi-omics integration, and artificial intelligence is transforming cancer screening. From the PATHFINDER 2 trial showing a seven-fold increase in cancer detection to the PROMISE…